Skip to content

PHARMACIE VANNESTE

Active
Public limited companyfounded 1989active for 37 yearsAvenue Eugène Mascaux 350, 6001 Charleroi, BelgiumKBO/BCE: BE 0436.660.940
Summary

PHARMACIE VANNESTE has been active since 1989 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €200,243 and a net result of €85,981. Equity remains stable across the filed financial years (±0.4% per year). Its solvency ranks better than 32% of 5,017 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Risk analysisFollow ReportCompare
PHARMACIE VANNESTEActiveChecked score 92/100
Risk analysis ReportCompare

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€966,243total assets 2025
Staff
1.4 FTE
Equity
€200,243
Profit
€85,981
Financial health
92 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Structure
Parent
PHARMACIE VANESSE · 100%
2025 accounts filed 20 days late4 of 8 deeds summarised
Why 92raises riskSector: Retail trade (NACE 47)Equity €200,243 (20.7% of total assets)lowers riskSize: 1.4 FTE, total assets €966,243Founded in 1989Show the evidence

Checked score

Score 2025
92 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 59% of its sector peers (NACE 47, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Average
Solvency 46-8
equity 20.7% of total assets
Liquidity 57-3
short-term debt 21.4% · cash 11.0%
Profitability 80+2
return on assets 8.9%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,246 companies, NACE 47, micro)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025lowest value 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.4%▲ +0.3 percentage points vs 07-2026highest value 09-2026: 0.1%▼ -0.3 percentage points vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026
Credit of up to €18,000 on 30-day terms is acceptable
Liquidity ample (current ratio 1.63, compared with 2.23 in 2024, above the usual 1.5; short-term debt: 21.4% and cash: 11% of total assets), but 79.3% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 37% on solvency, 63% on liquidity, 71% on profitability and 67% on growth.

The bankruptcy probability was computed on 26-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises risk
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Size: 1.4 FTE, total assets €966,243
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Founded in 1989
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
raises risk · Equity €200,243 (20.7% of total assets)
NBB · annual accounts
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year €200,243
raises risk · 2025 accounts filed 20 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 20-08-2026, 20 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
20 days late
2024
42 days early
2023
86 days early
2022
42 days late
2021
17 days late
2020
24 days late
2019
53 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 4 days after the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 17 August (4 of the last 5 filed years within 59 days of that day).
Companies Code · seven months
Where today falls in the filing period
27-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · full…
  2. Highest result from 2018 to 2025net €85,981 ▲92.6%
  3. Equity above €200,000equity €200,243 ▲14.9%

Key points

  • Positive: 8 profitable years in a rowprofit 2025: €85,981 8 years View
  • Controlled by PHARMACIE VANESSE 100% View
  • Active since 1989founded 30-01-1989 37 years View

By topic

Financials

Financial year
2025
Total assets
€966,243
Profit
€85,981
Solvency
20.7%
Total assets▲ 60.0%
Net result
20182025
Go to Financials

Timeline

Events
46
Since
1990
Next accounts
by 31-07-2027
  1. 19-06-2025Annual accounts filed
  2. 11-07-2024Resignations: Véronique Vanneste, Isabelle Vanneste and Yves…
  3. 06-05-2024Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
30-01-1989
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
36
Annual meeting
Last Saturday of June at 19:00
Purpose
“L’achat,la vente,l’importation,l’exportation de tous produits et articles pharmaceutiques…” (deed in French)
Statutory auditor
No statutory auditor
Go to Articles of association

Key facts about PHARMACIE VANNESTE

What is the company number of PHARMACIE VANNESTE?
0436.660.940. In Belgium the VAT number is the company number with BE in front: BE 0436.660.940.
Where is PHARMACIE VANNESTE based?
The registered office is at Avenue Eugène Mascaux 350, 6001 Charleroi.Company details
What does PHARMACIE VANNESTE do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of PHARMACIE VANNESTE?
Public limited company (NV).
When was PHARMACIE VANNESTE founded?
On 30-01-1989.
Is PHARMACIE VANNESTE still active?
Yes, PHARMACIE VANNESTE is an active enterprise in the KBO register.
How many employees does PHARMACIE VANNESTE have?
On average 1.4 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of PHARMACIE VANNESTE?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is PHARMACIE VANNESTE profitable?
In financial year 2025, PHARMACIE VANNESTE made a profit of €85,981.
Where can I find the annual accounts of PHARMACIE VANNESTE?
PHARMACIE VANNESTE filed 37 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PHARMACIE VANNESTE due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to PHARMACIE VANNESTE

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure